|Videos|January 14, 2013
How is Hepatitis C Treatment Changing?
Here, UCSF's Annie Luetkemeyer talks about new treatments for hepatitis C and what they will do for people with infections.
Advertisement
Here, UCSF's Annie Luetkemeyer talks about new treatments for hepatitis C and what they will do for people with infections.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
3
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
4
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
5